Adagene (ADAG) News Today → SHOCKING Crypto Leak… (From Crypto 101 Media) (Ad) Free ADAG Stock Alerts $2.80 +0.20 (+7.69%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 31 at 1:22 AM | americanbankingnews.comAdagene Inc. (NASDAQ:ADAG) Short Interest UpdateMay 30 at 3:20 AM | marketbeat.comAdagene Inc. (NASDAQ:ADAG) Sees Significant Decrease in Short InterestAdagene Inc. (NASDAQ:ADAG - Get Free Report) was the target of a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 11,100 shares, a drop of 26.5% from the April 30th total of 15,100 shares. Currently, 0.0% of the company's stock are short sold. Based on an average daily volume of 34,900 shares, the short-interest ratio is presently 0.3 days.May 29, 2024 | americanbankingnews.comHead-To-Head Survey: Galera Therapeutics (NASDAQ:GRTX) and Adagene (NASDAQ:ADAG)May 22, 2024 | globenewswire.comAdagene to Present at Investor Conferences in JuneMay 8, 2024 | marketbeat.comWuXi AppTec Co. Ltd. Takes Position in Adagene Inc. (NASDAQ:ADAG)WuXi AppTec Co. Ltd. acquired a new stake in Adagene Inc. (NASDAQ:ADAG - Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 4,225,696 shares of the company's stock, vApril 10, 2024 | investing.comMorgan Stanley lifts Adagene stock target on positive dataMarch 31, 2024 | finanznachrichten.deAdagene Inc.: Adagene Reports Full Year 2023 Financial Results and Provides Corporate UpdateMarch 29, 2024 | globenewswire.comAdagene Reports Full Year 2023 Financial Results and Provides Corporate UpdateMarch 7, 2024 | globenewswire.comAdagene Appoints Heinz-Josef Lenz, M.D., FACP to Scientific and Strategic Advisory BoardFebruary 27, 2024 | globenewswire.comAdagene to Present at the Leerink Partners Global Biopharma Conference 2024February 12, 2024 | marketbeat.comAdagene Inc. (NASDAQ:ADAG) Sees Significant Increase in Short InterestAdagene Inc. (NASDAQ:ADAG - Get Free Report) was the recipient of a significant increase in short interest in January. As of January 31st, there was short interest totalling 44,600 shares, an increase of 105.5% from the January 15th total of 21,700 shares. Currently, 0.1% of the company's stock are short sold. Based on an average daily volume of 104,900 shares, the short-interest ratio is presently 0.4 days.February 9, 2024 | finance.yahoo.comAdagene Announces Progress and Expansion of Clinical Collaboration Program for Masked, Anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with KEYTRUDA® (pembrolizumab) to Demonstrate Further Efficacy in Patients with Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)January 29, 2024 | marketbeat.comAdagene Inc. (NASDAQ:ADAG) Sees Large Decline in Short InterestAdagene Inc. (NASDAQ:ADAG - Get Free Report) was the target of a significant drop in short interest during the month of January. As of January 15th, there was short interest totalling 21,700 shares, a drop of 13.9% from the December 31st total of 25,200 shares. Approximately 0.1% of the company's shares are sold short. Based on an average trading volume of 85,400 shares, the short-interest ratio is currently 0.3 days.January 21, 2024 | seekingalpha.comWeek In Review: Lee's Pharm Signs $138M Agreement For China Rights To Heart Failure TherapyJanuary 19, 2024 | msn.comMesoblast rises after cell therapy gets FDA rare pediatric disease designationJanuary 18, 2024 | benzinga.comHow Is The Market Feeling About Adagene?January 17, 2024 | realmoney.thestreet.comMorgan Stanley 'encouraged' by 2 cPRs reported by AdageneJanuary 17, 2024 | benzinga.comWhy Is Cancer Focused Adagene Stock Plummeting Today?January 17, 2024 | msn.comAdagene falls after trial data for cancer therapyJanuary 16, 2024 | finance.yahoo.comAdagene Presents Interim Results Reinforcing Best-in-Class Profile of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in Metastatic Microsatellite-stable (MSS) Colorectal Cancer (CRC)January 10, 2024 | finance.yahoo.comAdagene Inc.'s (NASDAQ:ADAG) market cap surged US$34m last week, retail investors who have a lot riding on the company were rewardedJanuary 4, 2024 | finance.yahoo.comAdagene To Present Interim Results of Masked anti-CTLA-4 SAFEbody® ADG126 (muzastotug) in Combination with Pembrolizumab in MSS CRC at ASCO-GI SymposiumDecember 28, 2023 | msn.comNKGen doses first patient in Phase 1/2a Alzheimer's studyDecember 20, 2023 | realmoney.thestreet.comAdagene price target lowered by 40c at Morgan Stanley, here's whyDecember 19, 2023 | markets.businessinsider.comDeka Biosciences Adds Industry Veterans to its Executive Leadership Team and Board of DirectorsNovember 3, 2023 | finance.yahoo.comAdagene Presents Data Demonstrating the Best-in-Class Therapeutic Index for Masked Anti-CTLA-4 SAFEbody® ADG126 at SITC 2023October 13, 2023 | finance.yahoo.comAre Medical Stocks Lagging Medpace (MEDP) This Year?October 12, 2023 | finance.yahoo.comAdagene Announces Poster Presentation on Optimal Dose Selection for Masked Anti-CTLA-4 SAFEbody® ADG126 at Upcoming Society for Immunotherapy of Cancer (SITC) 38th Annual MeetingOctober 5, 2023 | msn.comAdagene Inc - ADR (ADAG) Price Target Increased by 9.87% to 14.04October 4, 2023 | markets.businessinsider.comAdagene’s Strong Potential: A Buy Rating Backed by Evorpacept Trials and Promising CD47-Targeted TherapiesSeptember 9, 2023 | finance.yahoo.comPotential Upside For Adagene Inc. (NASDAQ:ADAG) Not Without RiskSeptember 7, 2023 | finance.yahoo.comAdagene to Present at Investor and Scientific Conferences in SeptemberAugust 31, 2023 | finance.yahoo.comAdagene Reports Six Month Financial Results for 2023 and Provides Corporate UpdateAugust 8, 2023 | benzinga.comArtificial Intelligence (AI) in Drug Discovery Market Revenue To Surpass USD 11,914 Million By 2030July 21, 2023 | finance.yahoo.comAdvances in Cancer Immunotherapy: Breakthrough Techniques and Key Players Explored in New ReportJune 12, 2023 | markets.businessinsider.comH.C. Wainwright Sticks to Its Buy Rating for LAVA Therapeutics (LVTX)May 25, 2023 | finance.yahoo.comIs Adagene (ADAG) Stock Outpacing Its Medical Peers This Year?May 23, 2023 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: Poseida Therapeutics (PSTX), Mustang Bio (MBIO)May 4, 2023 | finance.yahoo.comAdagene Achieves $3 Million Milestone in Collaboration with Exelixis for Successful Nomination of Second SAFEbody® Novel Masked Antibody-Drug ConjugateApril 28, 2023 | finance.yahoo.comAdagene Announces Updates to its Board of DirectorsApril 22, 2023 | msn.comHC Wainwright & Co. Reiterates Adagene Inc - ADR (ADAG) Buy RecommendationApril 21, 2023 | markets.businessinsider.comExpert Ratings for AdageneApril 18, 2023 | finance.yahoo.comAdagene Presents Clinical Data for Anti-CTLA-4 SAFEbody® ADG126 Reinforcing Best-in-Class Safety Profile at Repeat Doses and Showing Early Efficacy Profile in Advanced/Metastatic Solid TumorsMarch 31, 2023 | msn.comAre Medical Stocks Lagging Adagene (ADAG) This Year?March 31, 2023 | finance.yahoo.comAre Medical Stocks Lagging Adagene (ADAG) This Year?March 31, 2023 | finance.yahoo.comAdagene Full Year 2022 Earnings: US$1.85 loss per share (vs US$1.83 loss in FY 2021)March 29, 2023 | finanznachrichten.deAdagene Inc.: Adagene Reports Full Year 2022 Financial Results and Provides Corporate UpdateMarch 28, 2023 | finance.yahoo.comAdagene Reports Full Year 2022 Financial Results and Provides Corporate UpdateMarch 21, 2023 | markets.businessinsider.comH.C. Wainwright Sticks to Its Buy Rating for Adagene (ADAG)March 16, 2023 | markets.businessinsider.comH.C. Wainwright Keeps Their Buy Rating on Hookipa Pharma (HOOK) Get Adagene News Delivered to You Automatically Sign up to receive the latest news and ratings for ADAG and its competitors with MarketBeat's FREE daily newsletter. Email Address What is Nvidia doing on June 10? June 10th is pivotal for Nvidia’s “Silent Partners” (Ad)A small handful of companies are working with Nvidia to help ensure that this pivot is a massive success. We call them Nvidia’s “Silent Partners.” Click here to find out who they are. ADAG Media Mentions By Week ADAG Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ADAG News Sentiment▼1.130.76▲Average Medical News Sentiment ADAG News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ADAG Articles This Week▼50▲ADAG Articles Average Week Get Adagene News Delivered to You Automatically Sign up to receive the latest news and ratings for ADAG and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: VSTM News Today CUE News Today XLO News Today CGEN News Today IPHA News Today LRMR News Today PEPG News Today MREO News Today KALV News Today AVTE News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ADAG) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden replacement revealed?Paradigm PressShocking: One AI startup's revenue could surge 4,735%Manward PressBiden Nomination CANCELED?The Freeport SocietyNvidia has Apple and Microsoft within striking rangeWeiss RatingsDon’t buy a single NVIDIA share before you see this...Behind the MarketsExposed: 10 CENT Crypto to Explode May 20th?True Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Adagene Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
